• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

ResMed (RMD)

Equity
Sell: $222.20|Buy: $275.00|Change: 0.34 (0.13%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care software the remainder. Growth depends on diagnosing more of the large untreated sleep apnea population and moving them onto therapy. The Americas contribute about two-thirds of device and mask revenue, with most of the rest from Europe, Japan, and Australia.

Address

9001 Spectrum Center Boulevard
San Diego
CA
USA
92123

Telephone

+1 858221330

Website

https://www.resmed.com

Sector 

Healthcare

Forecast key dates

NameKey Date
ResMed Inc First Quarter Earnings Conference Call for 20282027-10-29T16:30:00
ResMed Inc First Quarter Earnings Results for 20282027-10-29T00:00:00
ResMed Inc Annual Report for 20272027-08-13T00:00:00
ResMed Inc Fourth Quarter Earnings Conference Call for 20272027-08-06T16:30:00
ResMed Inc Fourth Quarter Earnings Results for 20272027-08-06T00:00:00
ResMed Inc Third Quarter Earnings Conference Call for 20272027-04-30T16:30:00
ResMed Inc Third Quarter Earnings Results for 20272027-04-30T00:00:00
ResMed Inc Second Quarter Earnings Conference Call for 20272027-01-29T16:30:00
ResMed Inc Second Quarter Earnings Results for 20272027-01-29T00:00:00
ResMed Inc Annual General Meeting for 20262026-11-18T15:00:00
ResMed Inc First Quarter Earnings Conference Call for 20272026-10-29T16:30:00
ResMed Inc First Quarter Earnings Result for 20272026-10-29T00:00:00

Previous key dates

NameKey Date
ResMed Inc First Quarter Earnings Conference Call for 20272026-10-29T16:30:00
ResMed Inc First Quarter Earnings Result for 20272026-10-29T00:00:00
24th Annual Morgan Stanley Global Healthcare Conference2026-09-15T10:00:00
ResMed Inc Annual Report for 20262026-08-13T00:00:00
ResMed Inc Fourth Quarter Earnings Conference Call for 20262026-08-06T16:30:00
ResMed Inc Fourth Quarter Earnings Result for 20262026-08-06T00:00:00
46th Annual William Blair Growth Stock Conference2026-06-02T16:40:00
ResMed Inc Third Quarter Earnings Conference Call for 20262026-04-30T16:30:00
ResMed Inc Third Quarter Earnings Result for 20262026-04-30T00:00:00
ResMed Inc Second Quarter Earnings Conference Call for 20262026-01-29T16:30:00
ResMed Inc Second Quarter Earnings Result for 20262026-01-29T00:00:00
44 Annual J.P. Morgan Healthcare Conference2026-01-12T10:30:00
ResMed Inc Annual General Meeting for 20252025-11-19T15:00:00
ResMed Inc First Quarter Earnings Conference Call for 20262025-10-30T16:30:00
ResMed Inc First Quarter Earnings Result for 20262025-10-30T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.